2-(2-(((3'-(Aminomethyl)-[1,1'-biphenyl]-3-yl)oxy)methyl)phenyl)acetic Acid

ID: ALA4473278

PubChem CID: 117819978

Max Phase: Preclinical

Molecular Formula: C22H21NO3

Molecular Weight: 347.41

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  NCc1cccc(-c2cccc(OCc3ccccc3CC(=O)O)c2)c1

Standard InChI:  InChI=1S/C22H21NO3/c23-14-16-5-3-8-17(11-16)18-9-4-10-21(12-18)26-15-20-7-2-1-6-19(20)13-22(24)25/h1-12H,13-15,23H2,(H,24,25)

Standard InChI Key:  OPJHZSZMYGOFEH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    2.2146  -23.0926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2107  -23.9101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9183  -24.3175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6263  -23.9077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6224  -23.0863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9143  -22.6826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9213  -25.1304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2125  -25.5392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2130  -26.3556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9217  -26.7642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6313  -26.3505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6273  -25.5354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5056  -26.7646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5061  -27.5818    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3280  -22.6741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.0378  -23.0791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7434  -22.6668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4514  -23.0768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1566  -22.6652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1528  -21.8472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4381  -21.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7359  -21.8563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4529  -23.8940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1613  -24.3013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1627  -25.1185    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8683  -23.8915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
  9 13  1  0
 13 14  1  0
  5 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 18 23  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
M  END

Associated Targets(Human)

CFD Tchem Complement factor D (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.41Molecular Weight (Monoisotopic): 347.1521AlogP: 4.02#Rotatable Bonds: 7
Polar Surface Area: 72.55Molecular Species: ZWITTERIONHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 4.01CX Basic pKa: 9.24CX LogP: 1.69CX LogD: 1.68
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.68Np Likeness Score: -0.35

References

1. Karki RG, Powers J, Mainolfi N, Anderson K, Belanger DB, Liu D, Ji N, Jendza K, Gelin CF, Mac Sweeney A, Solovay C, Delgado O, Crowley M, Liao SM, Argikar UA, Flohr S, La Bonte LR, Lorthiois EL, Vulpetti A, Brown A, Long D, Prentiss M, Gradoux N, de Erkenez A, Cumin F, Adams C, Jaffee B, Mogi M..  (2019)  Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.,  62  (9): [PMID:30995036] [10.1021/acs.jmedchem.9b00271]

Source